Question Should myocarditis be considered a potential adverse event following immunization with messenger RNA (mRNA) COVID-19 vaccines?
Findings In this case series of 23 male patients, including 22 previously healthy military members, myocarditis was identified within 4 days of receipt of a COVID-19 vaccine. For most patients (n = 20), the diagnosis was made after the second dose of mRNA COVID-19 vaccine; these episodes occurred against the backdrop of 2.8 million doses of mRNA COVID-19 vaccines administered.
Meaning
Vigilance for rare adverse events, including myocarditis,
after COVID-19 vaccination is warranted but should not diminish overall
confidence in vaccination during the current pandemic. more...
